Use of a special bioreactor for the cultivation of a new flexible polyurethane scaffold for aortic valve tissue engineering

BioMedical Engineering Online

Volumn 11, Issue , 2012, Pages

  Aleksieva, Genoveva ^a   Hollweck, Trixi ^a   Thierfelder, Nikolaus ^a   Haas, Ulrike ^a   Koenig, Fabian ^c   Fano, Cornelia ^b   Dauner, Martin ^b   Wintermantel, Erich ^c   Reichart, Bruno ^a   Schmitz, Christoph ^a   Akra, Bassil ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Institute of Textile Technology and Process Engineering   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Dynamic cultivation; Heart valve; Polyurethane scaffold; Static cultivation; Tissue engineering

Indexed keywords

ADHERENT CELLS; AORTIC VALVES; CELL BEHAVIORS; CELL DISTRIBUTION; CELL LAYERS; EXTRACELLULAR MATRICES; FLEXIBLE POLYURETHANES; HEART VALVE DISEASE; HEART VALVES; HIGH DENSITY; HUMAN VASCULAR ENDOTHELIAL CELLS; IMMUNOHISTOCHEMISTRY; IN-VITRO; INFLAMMATORY CYTOKINES; LOW FLOW CONDITION; POLYURETHANE SCAFFOLDS; REAL-TIME POLYMERASE CHAIN REACTION; SAPHENOUS VEIN; STATIC AND DYNAMIC; SURFACE VALVE; TISSUE-ENGINEERED HEART;

BIOCONVERSION; BIOMECHANICS; BIOREACTORS; CELL CULTURE; CELLS; HEART VALVE PROSTHESES; MECHANICAL PROPERTIES; POLYMERASE CHAIN REACTION; POLYURETHANES; SCANNING ELECTRON MICROSCOPY; TISSUE; TISSUE ENGINEERING;

SCAFFOLDS (BIOLOGY);

POLYURETHAN; TISSUE SCAFFOLD;

AORTA VALVE; ARTICLE; BIOREACTOR; CYTOLOGY; DRUG EFFECT; EXTRACELLULAR MATRIX; FIBROBLAST; GENE EXPRESSION REGULATION; HEART VALVE PROSTHESIS; HUMAN; METABOLISM; METHODOLOGY; TISSUE ENGINEERING; UMBILICAL VEIN ENDOTHELIAL CELL;

AORTIC VALVE; BIOREACTORS; EXTRACELLULAR MATRIX; FIBROBLASTS; GENE EXPRESSION REGULATION; HEART VALVE PROSTHESIS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; POLYURETHANES; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

MLCS; MLOWN;

EID: 84870328421     PISSN: None     EISSN: 1475925X     Source Type: Journal    
DOI: 10.1186/1475-925X-11-92     Document Type: Article

References (39)

1. Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg 2005, 79:1072-1080. 10.1016/j.athoracsur.2004.06.033, 15734452.
2. Huang G, Rahimtoola SH. Prosthetic heart valve. Circulation 2011, 123:2602-2605. 10.1161/CIRCULATIONAHA.110.979518, 21646507.
3. Sewell-Loftin MK, Chun YW, Khademhosseini A, Merryman WD. EMT-inducing biomaterials for heart valve engineering: taking cues from developmental biology. J CardiovascTtransl Res 2011, 4:658-671.
4. Cohen IS, Gaudette GR. Regenerating the Heart 2011, New York: Springer.
5. Weber B, Emmert MY, Schoenauer R, Brokopp C, Baumgartner L, Hoerstrup SP. Tissue engineering on matrix: future of autologous tissue replacement. Semin Immunopathol 2011, 33:307-315. 10.1007/s00281-011-0258-8, 21279358.
6. Meinel L, Fajardo R, Snyder B, Shinde-Patil V, Zichner L, Kaplan D, Langer R, Vunjak-Novakovic G. Bone tissue engineering using human mesenchymal stem cells: effects of scaffold material and medium flow. Ann Biomed Eng 2004, 32:112-122.
7. Cebotari S, Tudorache I, Schilling T, Haverich A. Heart valve and myocardial tissue engineering. Herz 2010, 35:334-341. 10.1007/s00059-010-3355-x, 20631970.
8. Gulbins H, Goldemund A, Anderson I, Haas U, Uhlig A, Meiser B, Reichart B. Preseeding with autologous fibroblasts improves endothelialization of glutaraldehyde-fixed porcine aortic valves. J Thorac Cardiovasc Surg 2003, 125:592-601. 10.1067/mtc.2003.48, 12658201.
9. König F, Hollweck T, Pfeifer S, Schmitz C, Reichart B, Wintermantel E, Akra B. A pulsatile bioreactor for conditioning of tissue-engineered cardiovascular constructs under endoscopic visualization. J Funct Biomater 2012, 3:480-496.
10. Khait L, Hecker L, Blan NR, Coyan G, Migneco F, Huang YC, Birla RK. Getting to the heart of tissue engineering. J Cardiovasc Transl Res 2008, 1:71-84. 10.1007/s12265-007-9005-x, 20559960.
11. Wintermantel E, Ha SW. Medizintechnik: Life Science Engineering 2008, Berlin, Heidelberg, New York: Springer Verlag GmbH.
12. Wintermantel E, Ha SW. Medizintechnik mit biokompatiblen Werkstoffen und Verfahren 2002, Berlin, Heidelberg, New York: Springer Verlag GmbH.
13. Schmidt D, Hoerstrup SP. Tissue engineered heart valves based on human cells. Swiss Med Wkly 2007, 3:480-496.
14. Stachelek SJ, Alferiev I, Connolly JM, Sacks M, Hebbel RP, Bianco R, Levy RJ. Cholesterol-modified polyurethane valve cusps demonstrate blood outgrowth endothelial cell adhesion post-seeding in vitro and in vivo. Ann Thorac Surg 2006, 81:47-55. 10.1016/j.athoracsur.2005.07.061, 16368333.
15. Rademacher A, Paulitschke M, Meyer R, Hetzer R. Endothelialization of PTFE vascular grafts under flow induces significant cell changes. Int J Artif Organs 2001, 24:235-242.
16. Consigny PM, Vitali NJ. Resistance of freshly adherent endothelial cells to detachment by shear stress is matrix and time dependent. J Vas Intery Radiol 1998, 9:479-485.
17. Kannan RY, Salacinski HJ, Butler PE, Hamilton G, Seifalian AM. Current status of prosthetic bypass grafts: a review. J Biomed Mater Res B Appl Biomater 2005, 74:570-581.
18. Georges PC, Janmey PA. Cell type-specific response to growth on soft materials. J Appl Physiol 2005, 98:1547-1553. 10.1152/japplphysiol.01121.2004, 15772065.
19. Barron V, Lyons E, Stenson-Cox C, McHugh PE, Pandit A. Bioreactors for cardiovascular cell and tissue growth: a review. Ann Biomed Eng 2003, 31:1017-1030.
20. Yeung T, Georges PC, Flanagan LA, Marg B, Ortiz M, Funaki M, Zahir N, Ming W, Weaver V, Janmey PA. Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion. Cell Motil Cytoskeleton 2005, 60:24-34. 10.1002/cm.20041, 15573414.
21. Sheikh S, Rainger GE, Gale Z, Rahman M, Nash GB. Exposure to fluid shear stress modulates the ability of endothelial cells to recruit neutrophils in response to tumor necrosis factor-alpha: a basis for local variations in vascular sensitivity to inflammation. Blood 2003, 102:2828-2834. 10.1182/blood-2003-01-0080, 12829609.
22. Syedain ZH, Meier LA, Bjork JW, Lee A, Tranquillo RT. Implantable arterial grafts from human fibroblasts and fibrin using a multi-graft pulsed flow-stretch bioreactor with noninvasive strength monitoring. Biomaterials 2011, 32:714-722. 10.1016/j.biomaterials.2010.09.019, 3042747, 20934214.
23. Tschoeke B, Flanagan TC, Cornelissen A, Koch S, Roehl A, Sriharwoko M, Sachweh JS, Gries T, Schmitz-Rode T, Jockenhoevel S. Development of a composite degradable/nondegradable tissue-engineered vascular graft. Artif Organs 2008, 32:800-809.
24. Sierad LN, Simionescu A, Albers C, Chen J, Maivelett J, Tedder ME, Liao J, Simionescu DT. Design and testing of a pulsatile conditioning system for dynamic endothelialization of polyphenol-stabilized tissue engineered heart valves. Cardiovasc Eng Technol 2010, 1:138-153. 10.1007/s13239-010-0014-6, 3039844, 21340043.
25. Mol A, Driessen NJ, Rutten MC, Hoerstrup SP, Bouten CV, Baaijens FP. Tissue engineering of human heart valve leaflets: a novel bioreactor for a strain-based conditioning approach. Ann Biomed Eng 2005, 33:1778-1788. 10.1007/s10439-005-8025-4, 16389526.
26. Ramaswamy S, Gottlieb D, Engelmayr GC, Aikawa E, Schmidt DE, Gaitan-Leon DM, Sales VL, Mayer JE, Sacks MS. The role of organ level conditioning on the promotion of engineered heart valve tissue development in vitro using mesenchymal stem cells. Biomaterials 2010, 31:1114-1125. 10.1016/j.biomaterials.2009.10.019, 2813971, 19944458.
27. Zeltinger J, Landeen LK, Alexander HG, Kidd ID, Sibanda B. Development and characterization of tissue-engineered aortic valves. Tissue Eng 2011, 7:9-22.
28. Fuster V, Alexander RW, O'Rourke RA. The Heart 2004, Inc, New York: The McGraw-Hill Companies.
29. Simionescu A, Schulte JB, Fercana G, Simionescu DT. Inflammation in cardiovascular tissue engineering: the challenge to a promise: a minireview. Int J Inflam 2011, 2011:1-11.
30. Montes-Worboys A, Rodriguez-Portal JA, Arellano-Orden E, Digon-Pereiras J, Rodriguez-Panadero F. Interleukin-8 activates coagulation and correlates with survival after talc pleurodesis. Eur Respir J 2010, 35:160-166. 10.1183/09031936.00146808, 19574329.
31. Nagel T, Resnick N, Atkinson WJ, Dewey CF, Gimbrone MA. Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells. J Clin Invest 1994, 94:885-891. 10.1172/JCI117410, 296171, 7518844.
32. Feghali CA, Wright TM. Cytokines in acute and chronic inflammation. Front Biosci 1997, 2:d12-d26.
33. Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding HA, Gimbrone MA, Luster AD, Luscinskas FW, Rosenzweig A. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 1999, 398:718-723. 10.1038/19546, 10227295.
34. McGill SN, Ahmed NA, Christou NV. Endothelial cells: role in Infection and Inflammation. World J Surg 1998, 22:171-178. 10.1007/s002689900366, 9451933.
35. Chiu JJ, Chen LJ, Lee PL, Lee CI, Lo LW, Usami S, Chien S. Shear stress inhibits adhesion molecule expression in vascular endothelial cells induced by coculture with smooth muscle cells. Blood 2003, 101:2667-2674. 10.1182/blood-2002-08-2560, 12468429.
36. McHale JF, Marshall D, Haskard DO. TNF-α and IL-1 sequentially induce endothelial ICAM-1 and VCAM-1 expression in MRL/lpr lupus-prone mice1. J Immunol 1999, 7:3993-4000.
37. Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Alexander RW, Medford RM. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 1993, 92:1866-1874. 10.1172/JCI116778, 288351, 7691889.
38. Rainwater DL, Shi Q, Mahaney MC, Hodara V, Vandeberg JL, Wang XL. Genetic regulation of endothelial inflammatory responses in baboons. Arterioscler Thromb Vac Biol 2010, 30:1628-1633.
39. Bottino R, Balamurugan AN, Tse H, Thirunavukkarasu C, Ge X, Profozich J, Milton M, Ziegenfuss A, Trucco M, Piganelli JD. Response of human islets to isolation stress and the effect of antioxidant treatment. Diabetes 2004, 53:2559-2568. 10.2337/diabetes.53.10.2559, 15448084.